/Investor DB

Mintaka — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Curve Biosciencescurvebio.cominOct 2025 · $40M

Curve Bio builds Whole-Body Intelligence models from its Whole-Body Atlas, a molecular map of the body, to power blood tests that monitor organ health in chronic disease patients.

AI & Machine LearningBiotechDigital HealthDallas, US

Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)

Co-investorsFirst Spark Ventures, LlcLifeX VenturesLuma GroupNZVCCivilization Ventures Management, Llc

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.